Jane Kendrew

4.1k citations
34 papers · 2.8k · 1 hit paper · h-index 22

Impact in

  • Oncology top 2%
    • HER2/EGFR in Cancer Research
    • Cancer Treatment and Pharmacology
    • Cancer, Hypoxia, and Metabolism

Papers in

    • Angiogenesis and VEGF in Cancer 21
    • PI3K/AKT/mTOR signaling in cancer 9
    • HER2/EGFR in Cancer Research 8

Jane Kendrew

34 papers receiving 2.7k citations

Jane Kendrew's Hit Papers

ZD6474 inhibits vascular endothelial growth factor signaling, angiogenesis, and tumor growth following oral administration. 2002 · 720 citations
7200+8+16Years since publication200400600

Peers

Jane Kendrew
Comparison fields: 5 of 94
  • Oncology 938
  • Cancer Research 488
  • Immunology and Allergy 120
  • Molecular Biology 1.4k
  • Pulmonary and Respiratory Medicine 486
Replace Dana D. Hu‐Lowe with:
Dana D. Hu‐Lowe United States
Jonathan M. Yingling United States
Kyle D. Holen United States
Laurent Hennequin France
Justin M. Summy United States
Tokuzo Arao Japan
Alejandro D. Ricart United States
George N. Naumov United States
Nila U. Parikh United States
Randall Schreck United States
Jane Kendrew relative to Dana D. Hu‐Lowe United States Dana D. Hu‐Lowe's profile →
Citations per field
00.5×1.5×
Dana D. Hu‐Lowe · 1×
Citations per year

Countries citing papers authored by Jane Kendrew

Since Specialization
Citations

This map shows the geographic impact of Jane Kendrew's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jane Kendrew with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jane Kendrew more than expected).

Fields of papers citing papers by Jane Kendrew

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jane Kendrew. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jane Kendrew. The network helps show where Jane Kendrew may publish in the future.

Co-authors

The 25 scholars most cited alongside Jane Kendrew, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jane Kendrew Line = papers co-authored together Jane Kendrew links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.

#Work
1
ZD6474 inhibits vascular endothelial growth factor signaling, angiogenesis, and tumor growth following oral administration.
Hit paper breakdown →
2002720
2 2002263
3 1999203
4
ZD4190: an orally active inhibitor of vascular endothelial growth factor signaling with broad-spectrum antitumor efficacy.
2000172
5 2000149
6 2010124
7 2013120
8 2004120
9 2003110
10 2005109
11 201278
12 200277
13 200872
14 201172
15 200367
16 200752
17 200349
18 201247
19 200738
20 201130

About Jane Kendrew

Jane Kendrew is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Immunology and Allergy, having authored 34 papers that have together received 2.8k indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (21 papers), PI3K/AKT/mTOR signaling in cancer (9 papers), HER2/EGFR in Cancer Research (8 papers), Cell Adhesion Molecules Research (5 papers), Cancer, Hypoxia, and Metabolism (5 papers), MRI in cancer diagnosis (3 papers), Quinazolinone synthesis and applications (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). The work is most often cited by research in Oncology (938 citations), Cancer Research (488 citations), Immunology and Allergy (120 citations), Molecular Biology (1.4k citations) and Pulmonary and Respiratory Medicine (486 citations). Jane Kendrew has collaborated with scholars based in United Kingdom, France and Singapore. Frequent co-authors include Stephen R. Wedge, Laurent Hennequin, Jon Curwen, Donald Ogilvie, Elaine S. E. Stokes, Michael Dukes, Andrew P. Thomas, Brenda J Curry, P.F. Wadsworth and Helen Musgrove. Their work appears in journals such as Molecular Cancer Therapeutics, Clinical Cancer Research, Cancer Research, Bioorganic & Medicinal Chemistry Letters and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact